AMEDISYS Reports Total Revenue of $553 Million for Second Quarter of FY2023, Down 0.9% Year-over-Year

🌥️Earnings Overview

For the second quarter of FY2023 ending June 30 2023, Amedisys ($NASDAQ:AMED) reported total revenue of USD 553.0 million, which demonstrated a year-on-year decrease of 0.9%. Net income for the period was USD -80.3 million, in comparison to the prior year quarter’s figure of USD 29.6 million.

Analysis

GoodWhale has conducted an analysis of AMEDISYS‘s financials and given it a Risk Rating. According to the report, AMEDISYS is a medium risk investment in terms of both financial and business aspects. GoodWhale has also detected three risk warnings in income statement, balance sheet, and non-financial statements. To view the full details of these warnings, users must become a registered user of GoodWhale. The report is comprehensive and includes multiple detailed analyses of the business’s financial health. It is important for investors to review the report so that they can make informed decisions about their investments. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Amedisys. AMEDISYS_Reports_Total_Revenue_of_553_Million_for_Second_Quarter_of_FY2023_Down_0.9_Year-over-Year”>More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Amedisys. AMEDISYS_Reports_Total_Revenue_of_553_Million_for_Second_Quarter_of_FY2023_Down_0.9_Year-over-Year”>More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Amedisys. AMEDISYS_Reports_Total_Revenue_of_553_Million_for_Second_Quarter_of_FY2023_Down_0.9_Year-over-Year”>More…

Key Ratios Snapshot

Some of the financial key ratios for Amedisys are shown below. AMEDISYS_Reports_Total_Revenue_of_553_Million_for_Second_Quarter_of_FY2023_Down_0.9_Year-over-Year”>More…

Peers

Its competitors include National Healthcare Corp, Aveanna Healthcare Holdings Inc, and Nova Leap Health Corp.

– National Healthcare Corp ($NYSEAM:NHC)

National Healthcare Corporation is a diversified healthcare services company that owns and operates long-term care facilities, hospitals, home health agencies, and hospice care businesses. The company has a market capitalization of $942.75 million and a return on equity of 2.65%. National Healthcare Corporation is headquartered in Nashville, Tennessee.

– Aveanna Healthcare Holdings Inc ($NASDAQ:AVAH)

Aveanna Healthcare Holdings Inc is a publicly traded company that provides health care services. The company has a market capitalization of 290.03 million as of 2022 and a return on equity of -71.08%. The company’s primary business is providing in-home health care services to patients. The company operates in the United States, Canada, and Puerto Rico.

– Nova Leap Health Corp ($TSXV:NLH)

Nova Leap Health Corp is a Canadian publicly traded company with a market cap of 23.25M as of 2022. The company is a provider of home health care services. The company has a Return on Equity of 1.6%. The company’s services include personal care, nursing, and homemaking services.

Summary

Amedisys, Inc. reported total revenue of $553.0 million for the second quarter of FY2023 ending June 30, 2023, a slight decrease of 0.9% year-over-year. Net income for the quarter was reported at a loss of $80.3 million, compared to a profit of $29.6 million in the same quarter the previous year. Investors should carefully analyze Amedisys’ performance and consider the impact of the pandemic on its financials, as well as future prospects for growth.

Financial metrics that could be monitored include profitability, liquidity, solvency, efficiency, and capital structure. It is also important to research Amedisys’ competitors in the home health care industry in order to gain a better understanding of the current market conditions.